Haifeng Zhou

nanjing medical university

H指数:28

被引数:3,655

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Single-cell transcriptomic profiling of immune microenvironment remodeling in unresectable hepatocellular carcinoma after TACE combined therapies

不可切除肝细胞癌经TACE联合治疗后免疫微环境重塑的单细胞转录组分析

International Immunopharmacology

IF4.7

2026-07-210

PRE

Data-driven cluster analysis and external validation identify phenotypic subgroups in renin-independent aldosteronism with differential cardiovascular risk and therapeutic implications

数据驱动的聚类分析和外部验证识别出在肾素非依赖性醛固酮增多症中具有差异心血管风险和治疗意义的表型亚组

Frontiers in Endocrinology

IF4.6

2025-12-150

OAAI

Prognostic Value of the Ki-67 Index in Patients with Early Recurrent Hepatocellular Carcinoma Undergoing Postoperative Transarterial Chemoembolization

Ki-67指数对接受术后经动脉化疗栓塞治疗的早期复发肝癌患者的预后价值

European Journal of Surgical Oncology

IF2.9

2025-12-080

PRE

Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trial

efsubaglutide alfa在2型糖尿病患者中的有效性与安全性（SUPER1）：一项随机、双盲、安慰剂对照的IIb/III期试验

Diabetologia

IF10.2

2025-11-210

PRE

Dalong Zhu; Jianhua Ma; Weimin Wang; Bimin Shi; Xiaolin Dong; Fang Bian; Qingju Li; Yihua Wang; Chengyan Jiang; Xueying Wang; Kun Wang; Hongwei Ling; Xiaoxia Shi; Zhifeng Cheng; Guoyue Yuan; Liping Li; Xiuhai Su; Yibing Lu; Weihong Song; Yawei Zhang; Wen Hu; Xin Zhang; Haifang Wang; Yu Liu; Jifang Li; Lili Zhang; Yan Liu; Xiaokun Sun; Xiaoyue Wang; Keqin Zhang; Yongcai Zhao; Lili Zhang; Tianrong Pan; Ping Li; Shu Li; Haifeng Zhou; Chengxia Jiang; Xin Zheng; Lin Ni; Bo Feng; Feng Li; Lianshan Piao; Hongwei Jin; Yang Liu; Hongyi Cao; Yufeng Li; Hanqing Cai; Hong Mao; Yongqian Liang; Jianchao Guo; Yangang Wang; Yan Li; Ning Xu; Jinan Zhang; Qiu Zhang; Wuyan Pang; Jianxin Yu; Yulong Xu; Yue Zhou; Yiming Li; Qinghua Wang

Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204)

使用影像生物标志物解码肿瘤异质性可预测TACE联合免疫治疗和靶向治疗在HCC中的疗效（CHANCE2204）

HEPATOLOGY

IF15.8

2025-11-013

PRE

Jin, Zhi-Cheng; Wei, Jingwei; Xiao, Yu-Dong; Si, Anfeng; Chen, Jian-Jian; Zhu, Xiao-Li; Li, Jin-Ze; Nie, Fang; Ding, Rong; Zhou, Hai-Feng; Ding, Wei; Zhong, Bin-Yan; Xie, Yangyang; Hu, Hong-Tao; Yin, Guo-Wen; Ji, Jian-Song; Zhang, Wei-Hua; Shi, Hai-Bin; Wu, Jian-Bing; Xu, Guo-Hui; Yuan, Chun-Wang; Yang, Wei-Zhu; Liu, Rui-Bao; Wu, Ye-Ming; Zheng, Chuan-Sheng; Xu, Ai-Bing; Huang, Ming-Sheng; Li, Jia-Ping; Chen, Li; Wen, Shu-Wei; Wang, Yu-Qing; Gu, Shan-Zhi; Li, Dongrui; Wang, Duo; Zhou, Guan-Hui; Wang, Wei-Dong; Peng, Zhenwei; Wang, Xinying; Zhu, Hai-Dong; Tian, Jie; Teng, Gao-Jun

Dexmedetomidine alleviates sepsis-induced acute lung injury by inhibiting M1 macrophage polarization via inhibition of PKM2-mediated Warburg effect

右美托咪定通过抑制PKM2介导的Warburg效应来抑制M1巨噬细胞极化，从而减轻脓毒症诱导的急性肺损伤。

Biochemical Pharmacology

IF5.6

2025-07-050

PRE

Myocardial mitochondrial antiviral signaling protein promotes heart Ischemia-reperfusion injury via RIG-I signaling in mice

心肌线粒体抗病毒信号蛋白通过RIG-I信号通路促进小鼠心脏缺血再灌注损伤

Nature Communications

IF15.7

2025-06-020

OAAI